Israel’s Globes newspaper is reporting that Ocon Medical is about to begin clinical trials of company’s IUB (Intra Uterine Ball) contraceptive device that was designed to solve a few of the possible implantation downsides of current offerings, such as malpositioning, perforations, and expulsions.
The IUB takes advantage of shape memory alloys, such as those found in vascular stents, to be deployed through a catheter and unfurl into a sphere inside the uterine cavity.
From the product page:
When deployed into the uterine cavity, the IUB™ turns away from the fundus, maintains a diameter larger than the cervical canal and has superior flexibility and minimal tissue protrusion compared to current devices. These characteristics are expected to reduce the rate of complications and side effects.
In addition to these benefits, no special clinician training is required to start using the IUB™. The IUB™ shares the same indications with current IUDs and is positioned to be highly competitive with quality IUDs.
The IUB™ is a platform that will be used to create a line of products. The copper SCu300A IUB™ will be first introduced. Additional products in development are the SCu380A IUB™ as well as drug and hormone eluting versions of the IUB™.
Product page: Ocon Medical IUB…
More from Globes: Ocon Medical begins human trial on new IUD…